
08/29/2025
NeuroStar TMS therapy isn’t just for adults—it’s making a real difference for teens, too. 💚
Greenbrook now offers NeuroStar® TMS for ages 15–21, a non-drug, non-invasive treatment option for adolescent depression. Nearly half of teens see symptom relief after treatment.*
Here’s what makes it work:
✅ FDA-cleared for teens
✅ Administered in-clinic by our Care Team
✅ No systemic side effects
✅ Insurance-friendly (we handle it all)
Let’s give teens access to mental health care that truly works.
🔗Visit https://bit.ly/42NyzAw to learn more or schedule a free consultation.
*FDA Clearance K231926 (2024). The outcomes reported represent the subset of study patients for which the CGI-S and GAD-7 data was reported before and after an acute course of NeuroStar TMS. Patients aged 12 to 21 (average 19.2 ± 1.5) were treated under real-world conditions where patients may have been prescribed concomitant depression treatments including medications. “Measurable relief” was defined as a CGI-S score ≤3 and “complete remission” was defined as a CGI-S score ≤2 at the end of treatment.